A detailed history of Chilton Investment CO Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Chilton Investment CO Inc. holds 3,190 shares of LLY stock, worth $2.92 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,190
Previous 3,057 4.35%
Holding current value
$2.92 Million
Previous $1.78 Million 39.3%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $78,762 - $105,373
133 Added 4.35%
3,190 $2.48 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $25,209 - $29,718
-48 Reduced 1.55%
3,057 $1.78 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $459,912 - $634,059
1,058 Added 51.69%
3,105 $1.67 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $147,310 - $196,971
-420 Reduced 17.02%
2,047 $960,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $766,324 - $900,010
2,467 New
2,467 $847,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chilton Investment CO Inc. Portfolio

Follow Chilton Investment CO Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Investment CO Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chilton Investment CO Inc. with notifications on news.